Role of Serum Lactate Dehydrogenase as a Bio-Marker in Therapy Related Hematological Malignancies

Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients

Francesco Onida, Hagop M. Kantarjian, Terry L. Smith et al. · Blood · 2002 · 386 citations · Full text

Medicine, Hematology, Oncology +15

Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma

Luis F. Porrata, Morie A. Gertz, David J. Inwards et al. · Blood · 2001 · 268 citations · Full text

Medicine, Hematology, Immunology +17

Prognostic factors in aggressive non-Hodgkin's lymphoma: who has "high- risk" disease?

MA Shipp · Blood · 1994 · 248 citations · Full text

Medicine, Oncology, Pathology +9

Prognostic factors in aggressive non-Hodgkin's lymphoma: who has "high- risk" disease?

MA Shipp · Blood · 1994 · 217 citations · Full text

Medicine, Oncology, Pathology +9

High Serum Lactate Dehydrogenase Level as a Marker for Drug Resistance and Short Survival in Multiple Myeloma

Meletios Α. Dimopoulos, Bart Barlogie, Terry L. Smith et al. · Annals of Internal Medicine · 1991 · 208 citations

Medicine, Oncology, Pharmacology +13